Literature DB >> 16996505

Muscle atrophy in transgenic mice expressing a human TSC1 transgene.

Min Wan1, Xiaohui Wu, Kun-Liang Guan, Min Han, Yuan Zhuang, Tian Xu.   

Abstract

Muscle mass is regulated by a wide range of hormonal and nutritional signals, such as insulin and IGF. Tuberous sclerosis complex (TSC) is an inherited hamartoma disease with tumor growth in numerous organs. TSC is caused by mutation in either TSC1 or TSC2 tumor suppressor genes that negatively regulate insulin-induced S6K activation and cell growth. Here we report that expression of human TSC1 (hTSC1) in mouse skeletal muscle leads to reduction of muscle mass. Expression of hTSC1 stabilizes endogenous TSC2 and leads to inhibition of the mTOR signaling. The hTSC1-mTSC2 hetero-complex and its downstream components remain sensitive to insulin stimulation and nutrition signals. This study suggests that an increase in the steady state level of resident TSC1-TSC2 complex is sufficient to reduce muscle mass and cause atrophy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996505     DOI: 10.1016/j.febslet.2006.09.008

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

Review 2.  Cellular mechanisms regulating protein synthesis and skeletal muscle hypertrophy in animals.

Authors:  Mitsunori Miyazaki; Karyn A Esser
Journal:  J Appl Physiol (1985)       Date:  2008-11-26

Review 3.  Calpain activity and muscle wasting in sepsis.

Authors:  Ira J Smith; Stewart H Lecker; Per-Olof Hasselgren
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

Review 4.  mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong?

Authors:  Robert A Frost; Charles H Lang
Journal:  Physiology (Bethesda)       Date:  2011-04

5.  Molecular mechanism of size control in development and human diseases.

Authors:  Xiaolong Yang; Tian Xu
Journal:  Cell Res       Date:  2011-04-12       Impact factor: 25.617

Review 6.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

7.  The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth.

Authors:  Sandra Schrötter; Christopher J Yuskaitis; Michael R MacArthur; Sarah J Mitchell; Aaron M Hosios; Maria Osipovich; Margaret E Torrence; James R Mitchell; Gerta Hoxhaj; Mustafa Sahin; Brendan D Manning
Journal:  Cell Rep       Date:  2022-05-17       Impact factor: 9.995

8.  Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes.

Authors:  Robert A Frost; Danuta Huber; Anne Pruznak; Charles H Lang
Journal:  J Cell Biochem       Date:  2009-12-01       Impact factor: 4.429

Review 9.  Interactions of the super complexes: When mTORC1 meets the proteasome.

Authors:  Olasunkanmi A J Adegoke; Brendan E Beatty; Scot R Kimball; Simon S Wing
Journal:  Int J Biochem Cell Biol       Date:  2019-10-31       Impact factor: 5.085

10.  Differential response of skeletal muscles to mTORC1 signaling during atrophy and hypertrophy.

Authors:  C Florian Bentzinger; Shuo Lin; Klaas Romanino; Perrine Castets; Maitea Guridi; Serge Summermatter; Christoph Handschin; Lionel A Tintignac; Michael N Hall; Markus A Rüegg
Journal:  Skelet Muscle       Date:  2013-03-06       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.